Galenica AG logo

GALE - Galenica AG Share Price

CHF62.45 0.0  0.0%

Last Trade - 11/05/21

Consumer Defensives
Mid Cap
Market Cap £2.43bn
Enterprise Value £2.89bn
Revenue £2.73bn
Position in Universe 278th / 1051
Unlock GALE Revenue
Relative Strength (%)
1m -0.13%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -13.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
2,915 3,009 3,141 3,165 3,301 3,480 3,547 3,648 +3.6%
-0.9 +2.8 +37.0 +31.7 -15.7 +39.1 -18.3 +8.44
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, GalenicaAG revenues increased 5% to SF3.48B. Net income applicableto common stockholders increased 38% to SF172.2M. Revenuesreflect Services segment increase of 6% to SF1.87B, Health& Beauty segment increase of 4% to SF1.6B, Other countriessegment increase of 21% to SF27.2M. Net income benefitedfrom Personnel costs decrease of 5% to SF442.9M (expense),Other Operating Income increase of 35% to SF7.3M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for GALE
Graphical History


GALE Revenue Unlock GALE Revenue

Net Income

GALE Net Income Unlock GALE Revenue

Normalised EPS

GALE Normalised EPS Unlock GALE Revenue

PE Ratio Range

GALE PE Ratio Range Unlock GALE Revenue

Dividend Yield Range

GALE Dividend Yield Range Unlock GALE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
GALE EPS Forecasts Unlock GALE Revenue
Profile Summary

Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated February 13, 2017
Public Since April 7, 2017
No. of Shareholders: n/a
No. of Employees: 5,538
Sector Consumer Defensives
Industry Food & Drug Retailing
Exchange SIX Swiss Exchange
Shares in Issue 49,498,560
Free Float (0.0%)
Eligible for
GALE Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for GALE
Upcoming Events for GALE
Monday 17th May, 2021
Dividend For GALE.S - 0.9000 CHF
Monday 17th May, 2021
Dividend For GALE.S - 0.9000 CHF
Frequently Asked Questions for Galenica AG
What is the Galenica AG share price?

As of 11/05/21, shares in Galenica AG are trading at CHF62.45, giving the company a market capitalisation of £2.43bn. This share price information is delayed by 15 minutes.

How has the Galenica AG share price performed this year?

Shares in Galenica AG are currently trading at CHF62.45 and the price has moved by -7.69% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Galenica AG price has moved by -28.43% over the past year.

What are the analyst and broker recommendations for Galenica AG?

Of the analysts with advisory recommendations for Galenica AG, there are there are currently 3 "buy" , 4 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Galenica AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Galenica AG next release its financial results?

Galenica AG is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Galenica AG dividend yield?

The Galenica AG dividend yield is 2.88% based on the trailing twelve month period.

Does Galenica AG pay a dividend?

Last year, Galenica AG paid a total dividend of 1.8, and it currently has a trailing dividend yield of 2.88%. Looking ahead, shares in Galenica AG are due to go ex-dividend on 2021-05-17 and the next dividend pay date is 2021-05-19.

When does Galenica AG next pay dividends?

Galenica AG are due to go ex-dividend on 2021-05-17 and the next dividend pay date is 2021-05-19. The historic dividend yield on Galenica AG shares is currently 2.88%.

How do I buy Galenica AG shares?

To buy shares in Galenica AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Galenica AG?

Shares in Galenica AG are currently trading at CHF62.45, giving the company a market capitalisation of £2.43bn.

Where are Galenica AG shares listed? Where are Galenica AG shares listed?

Here are the trading details for Galenica AG:

Country of listing: Switzerland
Exchange: SWX
Ticker Symbol: GALE
What kind of share is Galenica AG?

Based on an overall assessment of its quality, value and momentum, Galenica AG is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Galenica AG share price forecast 2021?

Shares in Galenica AG are currently priced at CHF62.45. At that level they are trading at 5.89% discount to the analyst consensus target price of 0.00.

Analysts covering Galenica AG currently have a consensus Earnings Per Share (EPS) forecast of 2.878 for the next financial year.

How can I tell whether the Galenica AG share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Galenica AG. Over the past six months, the relative strength of its shares against the market has been -10.11%. At the current price of CHF62.45, shares in Galenica AG are trading at 1.85% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Galenica AG PE Ratio?

The Galenica AG PE ratio based on its reported earnings over the past 12 months is 17.73. The shares are currently trading at CHF62.45.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Galenica AG?

Galenica AG's management team is headed by:

Daniela Bosshardt-Hengartner - NEC
Michel Burnier - IND
Felix Burkhard - CFO
Thomas Szuran - EXB
Daniele Madonna - EXB
Bertrand Jungo - NVC
Markus Neuhaus - IND
Pascale Bruderer - IND
Marc Werner - CEO
Andreas Koch - EXB
Virginie Jeschka - EXB
Barbara Walchli - SEC
Who are the major shareholders of Galenica AG?

Here are the top five shareholders of Galenica AG based on the size of their shareholding:

UBS Asset Management (Switzerland) Investment Advisor
Percentage owned: 5.34% (2.67m shares)
Alecta pensionsförsäkring, ömsesidigt Investment Advisor
Percentage owned: 4% (2.00m shares)
Credit Suisse Asset Management Investment Advisor/Hedge Fund
Percentage owned: 3.25% (1.63m shares)
Swisscanto Fondsleitung AG Investment Advisor
Percentage owned: 3.07% (1.53m shares)
Maag (Rudolf) Individual Investor
Percentage owned: 3% (1.50m shares)
Similar to GALE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.